SEL120-34A HCl is a hydrochloride salt form of a compound that acts as an inhibitor of cyclin-dependent kinases 8 and 19 (CDK8/19). It is used in pharmaceutical research as a selective CDK8/19 inhibitor for studying oncogenic signaling pathways and tumor cell proliferation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1609452-30-3
Silodosin
pharmaceutical raw material
(R/S)-silodosin
pharmaceutical raw material
Desisopropyl butyl torsemide
pharmaceutical raw material
Cromoglicic acid
pharmaceutical raw material
6,7-dibromo-5-methyl-2-piperazin-1-yl-1,3-diazatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraene;hydrochloride
GQXLWUCQESKBSC-UHFFFAOYSA-N
CC1=C2C3=C(CCCN3C(=N2)N4CCNCC4)C(=C1Br)Br.Cl